News Articles

In biotech, an open role is rarely “just an open role.” It’s not an empty chair waiting patiently to be filled when the timing feels right. It’s a pressure point that quietly spreads across teams, timelines, and outcomes. While budget discussions often focus on the salary attached to a position, the real cost of leaving a role unfilled is far more complex, and far more expensive.

Hiring in the life sciences is rarely one-size-fits-all. Between shifting funding cycles, regulatory milestones, and evolving pipelines, companies often face a critical decision: whether to hire contract talent or make permanent hires. Choosing the wrong approach can slow progress, increase costs, or introduce long-term risk, while the right strategy can keep programs moving and teams agile.